GINS2 and glioma: The results of the CCK-8, clone formation, tumor sphere formation, scratch, and Transwell migration and invasion assays showed that GINS2 promoted the malignant phenotype of glioma cells and attenuated their sensitivity to TMZ (Fig. 1D–H, Supplementary Fig. 4).